Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

Header Image: National Center for Infectious Diseases: Scientific Resources
Home | Drug Service | Specimens | Animals

Home
Drug Service
·Release Information
·Formulary
·References
Specimens
Animals
 
 DRUG SERVICE > References


References

  1. Botulism antitoxin bivalent (equine), types A and B (package insert). Toronto, Ontario, Canada: Aventis Pasteur Limited, 1997.
  2. Botulism antitoxin (equine), type E (package insert). Toronto, Ontario, Canada: Aventis Pasteur Limited, 1999.
  3. Centers for Disease Control and Prevention: Botulism in the United States, 1899-1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers, Atlanta, GA. Centers for Disease Control and Prevention, 1998.
  4. Grabenstein JD.  ImmunoFacts:  Vaccines & Immunologic Drugs.  St, Louis, MO:  Wolters Kluwer Health, Inc; 2004 (269, 342, 1019).
  5. Centers for Disease Control and Prevention: Availability of diphtheria antitoxin through an investigational new drug protocol. MMWR, May 21, 2004; 53(19):  413.
  6. Centers for Disease Control and Prevention. Smallpox Vaccination and Adverse Events:  Guidance for Clinicians. MMWR, February 21, 2003; 52(RR04);1-28.
  7. Centers for Disease Control and Prevention.  IND Protocol:  Use of Pentavalent (ABCDE) Botulinum Toxoid Aluminum Phosphate Adsorbed (PBT) for Workers at Risk of Occupational Exposure to Botulinum Toxoins.  BB-IND 161, March 27, 2006: version 6.
  8. Centers for Disease Control and Prevention.  Notice to Readers:  Newly Licensed Smallpox Vaccine to Replace Old Smallpox Vaccine.  MMWR, February 29, 2008 57(8); 207-208.
  9. Centers for Disease Control and Prevention. Vaccinia (Smallpox) Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, June 22, 2001 / 50(RR10);1-25.
  10. Centers for Disease Control and Prevention. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, December 15, 2000; 49(RR15);1-20.
  11. Centers for Disease Control and Prevention.  Intravenous Artesunate for Treatment of Severe Malaria in the United States.  IND Protocol #76,725; July, 2007: 1-48.
  12. Centers for Disease Control and Prevention. Bithionol IND Protocol #84,461; February, 1996:1-20.
  13. Centers for Disease Control and Prevention. Dehydroemetine IND Protocol #84,832; September, 2003:  1-13.
  14. Addis DG, Dreyer G. Treatment of lymphatic filariasis. In: Nutman, TB, ed. Chapter 7:  Treatment of Lymphatic Filariasis (Tropical Medicine: Science and Practice). London: Imperial College Press; 2000: 151-199.
  15. Centers for Disease Control and Prevention.  Diethylcarbamazine (DEC) for the treatment of filariasis.  IND Protocol #57,944; 2006:  1-33.
  16. Centers for Disease Control and Prevention. Melarsoprol IND Protocol #84,457; 1996:1-14.
  17. Centers for Disease Control and Prevention. Nifurtimox IND Protocol #84,422; 1987:1-11.
  18. Centers for Disease Control and Prevention. Pentostam IND Protocol #84,831; 1995:1-20.
  19. Herwaldt, B, Berman, J.  “Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies” Am J of Med Hyg; 46(3), 1992: 296–306.
  20. Centers for Disease Control and Prevention. Suramin IND Protocol #84,459; September, 1997:  1-11. 



Home | Division Home
CDC Home | Search | Health Topics A-Z

This page optimized for 800x600

Centers for Disease Control and Prevention
National Center for Infectious Diseases